Third, Smaducin-6, which blocks Peli1-mediated NF-κB activation, inhibits inflammatory responses and cell death in human placental trophoblasts and hNSCs, reduces placenta inflammation, and attenuates congenital malformations in mice. This evidence concerns the gene NFKB1 and pregnancy disorder.